Inventor · disambiguated record
Sabine Pestel
Also filed as: PESTEL SABINE
22 granted patents·17 pending applications·166 citations·filing 2003–2022
94Inventor score
Files withBOEHRINGER INGELHEIM PHARMA16BOEHRINGER INGELHEIM INT11CSL Behring Lengnau AG9BOUYSSOU THIERRY1CSL BEHRING RECOMBINANT FACILITY AG1
Top patents by PatentIndex Score
39 records- 0195US7056916B2Medicaments for the treatment of chronic obstructive pulmonary diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 6, 2006·43 cites·20 claims
- 0293US7727984B2Medicaments for the treatment of chronic obstructive pulmonary diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Jun 1, 2010·9 cites·4 claims
- 0392US6696462B2Anticholinergics, processes for the preparation thereof, and pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Feb 24, 2004·37 cites·35 claims
- 0488US6951888B2Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 4, 2005·22 cites·31 claims
- 0588US6790856B2Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Sep 14, 2004·17 cites·31 claims
- 0686US8044046B2Medicaments for the treatment of chronic obstructive pulmonary diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Oct 25, 2011·2 cites·5 claims
- 0786US7214797B2Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 8, 2007·4 cites·8 claims
- 0885US7786111B2Medicaments for the treatment of chronic obstructive pulmonary diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Aug 31, 2010·5 cites·36 claims
- 0984US10688157B2Truncated von Willebrand factor polypeptides for treating hemophiliaCSL Behring Lengnau AG·Filed 2016·Granted Jun 23, 2020·2 cites·23 claims
- 1082US10905747B2Methods for preparing modified von Willebrand factorCSL Behring Lengnau AG·Filed 2020·Granted Feb 2, 2021·1 cites·14 claims
- 1182US7135500B2Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticalsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Nov 14, 2006·16 cites·16 claims
- 1277US6998406B2Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Feb 14, 2006·4 cites·12 claims
- 1377US6815452B2Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Nov 9, 2004·4 cites·16 claims
- 1470US2009181961A1Novel medicaments for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 1568US11564976B2Methods for preparing modified von Willebrand FactorCSL Behring Lengnau AG·Filed 2020·Granted Jan 31, 2023·0 cites·15 claims
- 1668US2006106213A1New Medicaments for the Treatment of Chronic Obstructive Pulmonary DiseaseBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1767US2008167298A1Medicaments for the treatment of chronic obstructive pulmonary diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2008·Application pending·0 cites
- 1863US7429600B2Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Sep 30, 2008·0 cites·20 claims
- 1959US2005234134A1Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Application pending·0 cites
- 2056US10772936B2Methods for preparing modified von Willebrand factorCSL Behring Lengnau AG·Filed 2016·Granted Sep 15, 2020·0 cites·13 claims
- 2156US2008132556A13-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseasesBOUYSSOU THIERRY·Filed 2008·Application pending·0 cites
- 2256US2005107417A1Medicaments for inhalation comprising a novel anticholinergic and a betamimeticBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2356US2005042176A1Medicaments for inhalation comprising a novel anticholinergic and a steroidBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2456US2005043343A1Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitorBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2554US7511067B23-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Granted Mar 31, 2009·0 cites·6 claims
- 2654US2007203125A1Medicament Combinations for the Treatment of Respiratory DiseasesBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 2752US2024293516A1Factor ix subcutaneous administration with enhanced safetyCSL Behring Lengnau AG·Filed 2022·Application pending·0 cites
- 2851US2005239778A1Novel medicament combinations for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2950US2005272726A1Novel medicaments for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 3047US2009324510A1Drug combinations for the treatment of respiratory tract diseasesBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 3147US2008051392A1Pharmaceutical combinations for the treatment of respiratory diseasesKONETZKI INGO·Filed 2007·Application pending·0 cites
- 3245US2007037781A1Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredientBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 3345US2010297028A1Medicament combinations for the treatment of respiratory diseasesBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 3444US11141466B2Modulation of FVIII immunogenicity by truncated VWFCSL Behring Lengnau AG·Filed 2018·Granted Oct 12, 2021·0 cites·20 claims
- 3544US7405224B2Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jul 29, 2008·0 cites·16 claims
- 3643US11890327B2Truncated von Willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorderCSL Behring Lengnau AG·Filed 2017·Granted Feb 6, 2024·0 cites·23 claims
- 3743US11814421B2Truncated von Willebrand Factor polypeptides for treating hemophiliaCSL Behring Lengnau AG·Filed 2017·Granted Nov 14, 2023·0 cites·24 claims
- 3837US11155601B2Modified von Willebrand factor having improved half-lifeCSL Behring Lengnau AG·Filed 2016·Granted Oct 26, 2021·0 cites·13 claims
- 3936US2018043012A1Compounds for improving the half-life of von willebrand factorCSL BEHRING RECOMBINANT FACILITY AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →